PLUS1
62.34
1.17 (1.91%)
1.17 (1.91%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alcon Inc | ALC | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.17 | 1.91% | 62.34 | 20:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 62.34 | 62.0375 | 62.50 | 62.31 | 61.17 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,422 | 1,161,419 | $ 62.31 | $ 72,372,569 | 1,195,705 | 39.37 - 65.37 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 47,084 | $ 62.34 | USD |
Alcon Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 30.49B | 489.10M | 489.10M | $ 7.51B | $ -861.17M | -1.34 | -35.41 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 5.07M | $ - | 0.00% | - | - |
Alcon News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/08/2020 | 08:00 | Business Wire | Alcon Celebrates World Sight Day 2020 and Continues.. |
| 10/06/2020 | 08:15 | Business Wire | Alcon to Showcase Innovations at #Academy20 that Support.. |
| 9/10/2020 | 15:58 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) |
| 8/20/2020 | 08:00 | Business Wire | Alcon and Actress Katherine McNamara Encourage Consumers to.. |
| 8/18/2020 | 16:56 | Business Wire | Alcon Reports Second Quarter 2020 Results |
| 8/18/2020 | 16:35 | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) |
| 8/18/2020 | 16:30 | Business Wire | Alcon Reports Second Quarter 2020 Results |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 61.65 | 62.71 | 59.705 | 61.01 | 842,283 | 0.69 | 1.12% |
| 1 Month | 55.82 | 63.38 | 55.82 | 59.42 | 972,867 | 6.52 | 11.68% |
| 3 Months | 61.98 | 63.38 | 54.51 | 58.70 | 1,192,825 | 0.36 | 0.58% |
| 6 Months | 52.89 | 64.92 | 49.64 | 58.39 | 1,298,097 | 9.45 | 17.87% |
| 1 Year | 58.05 | 65.37 | 39.37 | 56.82 | 1,318,061 | 4.29 | 7.39% |
| 3 Years | 58.245 | 65.37 | 39.37 | 57.43 | 1,308,314 | 4.10 | 7.03% |
| 5 Years | 58.245 | 65.37 | 39.37 | 57.43 | 1,308,314 | 4.10 | 7.03% |
Alcon Description
| Alcon, headquartered in Fort Worth, Texas, is the global eye care leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with 41% of revenue in the U.S. market, and the firm has a strong presence in the European Union and Japan. |
